GlassScriptPhysician profile
James Rasmussen
NPI 1770661712
$3,143.76
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $705 · 2021: $1,998 · 2022: $314 · 2023: $126.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $126.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $126.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $841.82 | 2020-2023 | Fasenra |
| Intuitive Surgical, INC. | $476.32 | 2021 | |
| Glaxosmithkline, LLC. | $423.40 | 2020-2023 | Trelegy Ellipta, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $358.97 | 2020-2021 | |
| Boston Scientific Corporation | $201.31 | 2022-2023 | Emblem Mri S-Icd |
| Mylan Specialty L.P. | $173.39 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $97.80 | 2020-2021 | |
| Teva Pharmaceuticals USA, INC. | $82.29 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $60.74 | 2021-2022 | |
| Genzyme Corporation | $51.90 | 2020-2021 | |
| Amarin Pharma, INC. | $47.21 | 2020 | |
| Novartis Pharmaceuticals Corporation | $43.67 | 2020-2021 | |
| Janssen Pharmaceuticals, INC | $42.20 | 2020-2021 | |
| Sunovion Pharmaceuticals INC. | $40.20 | 2020 | |
| Jazz Pharmaceuticals INC. | $36.71 | 2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $35.08 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $30.86 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.25 | 2021 | |
| Inogen, INC. | $16.19 | 2021 | |
| Insmed, INC. | $15.54 | 2021 | |
| Merck Sharp & Dohme LLC | $13.46 | 2021 | |
| Genentech USA, INC. | $13.45 | 2022 | |
| Chiesi USA, INC. | $12.15 | 2021 | |
| Harmony Biosciences LLC | $11.85 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Rasmussen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.